Psychedelic Drugs in Biomedicine

Kyzar, Evan J., Nichols, Charles D., Gainetdinov, Raul R., Nichols, David E., Kalueff, Allan V.·2017·Trends in Pharmacological Sciences
DOI 10.1016/j.tips.2017.08.003

Cited by (155)

Items 101–155 of 155

  1. Exploring CNS Effects of American Traditional Medicines using Zebrafish Models
    Allan V. Kalueff, Murilo S. de Abreu, Fabiano Costa, Ana C.V.V. Giacomini, Konstantin A. Demin, Elena V. Petersen, Denis Broock Rosemberg · 2021 · Current Neuropharmacology
  2. Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?
    Genís Oña, José Carlos Bouso · 2019 · Preprints.org
  3. Psychedelic drugs as a long-needed innovation in psychiatry
    Genís Oña, José Carlos Bouso · 2020 · Qeios
  4. Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation
    Jerome Herpers, Natalie Maximets, Noah N. N. van Dongen, Josjan Zijlmans, Eric H. G. J. M. Vermetten · 2024 · European Journal of Psychotraumatology
  5. Trauma and Remembering: From Neuronal Circuits to Molecules
    Szabolcs Kéri · 2022 · Life
  6. A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness
    Jaden Brandt · 2023 · Drug Science Policy and Law
  7. Therapeutic Use of Hallucinogens
    Victor Distefano Wiltenburg, Dianne da Rocha Prado, Fúlvio Rieli Mendes · 2021 · Springer eBooks
  8. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats
    Piotr Popik, Martyna Krawczyk, Agata Kuziak, Ryszard Bugno, Adam S. Hogendorf, Jakub Staroń, Agnieszka Nikiforuk · 2019 · Journal of Psychopharmacology
  9. Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism
    Emma M. Bonniwell, Rana Alabdali, Joseph J. Hennessey, John L. McKee, Natalie G. Cavalco, Josie C Lammers, Ethan J. Moore, Luca Franchini, Cesare Orlandi, John D. McCorvy · 2025 · ACS Chemical Neuroscience
  10. Psychedelic Medicines in Major Depression: Progress and Future Challenges
    José Carlos Bouso, Genís Oña, RAFAEL GUIMARÃES DOS SANTOS, Jaime E. C. Hallak · 2021 · Advances in experimental medicine and biology
  11. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators.
    Martin G. Myers, C B Toal · 1995 · PubMed
  12. Traditional Indigenous-Amazonian Therapy Involving Ceremonial Tobacco Drinking as Medicine: A Transdisciplinary Multi-Epistemic Observational Study
    Ilana Berlowitz, Ernesto García Torres, Juan Celidonio Ruiz Macedo, Ursula Wolf, Caroline Maake, Chantal Martin-Söelch · 2024 · Health Education & Behavior
  13. Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
    Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, Jeonghyeon Choi, Mingon Kang, Jae‐Yeol Joo · 2025 · Advanced Science
  14. DMT-induced shifts in criticality correlate with ego-dissolution
    Mona Irrmischer, Marco Aqil, Lisa Xiaolu Luan, Tongyu Wang, Hessel Engelbregt, Robin Lester Carhart-Harris, Klaus Linkenkaer‐Hansen, Christopher Timmermann · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Exploring a Druggable Hydrophobic Tunnel in the 5-HT2A Receptor with Potent Phenethylamines
    Ícaro A. Simon, Eline Pottie, Madeleine K. Jensen, Kasper Harpsøe, Anders A. Jensen, Jesper Langgaard Kristensen, Christophe Pol Stove, Christian B. M. Poulie · 2026 · Journal of Medicinal Chemistry
  16. The metaphysics behind pharmacotherapy: treating depression with conventional and psychedelic drugs
    Virginia Ballesteros · 2018 · Psicología Conocimiento y Sociedad
  17. Psychedelic drugs as a long-needed innovation in psychiatry
    Genís Oña, José Carlos Bouso · 2020 · Qeios
  18. Effects of awe on self-transcendence: A registered report study
    Chenxiao Zhao, Marret K. Noordewier, Michiel van Elk · 2025 · Journal of Experimental Social Psychology
  19. Hallucinations and Imagination
    Daniel Collerton, Elaine King Perry, Alan Robert Bowman · 2020 · Cambridge University Press eBooks
  20. Responding to existential distress at the end of life: Psychedelics and psychedelic experiences and/ as medicine
    Nathan Emmerich · 2024 · Neuroethics
  21. Serotonergic psychedelics as potential therapeutics for post-COVID-19 syndrome (or Long COVID): A comprehensive review
    Zhen Xuen Brandon Low, Shin Jie Yong, Hayam Ali AlRasheed, Maha F. Al‐Subaie, Nawal Al Kaabi, Mubarak Saif Alfaresi, Hawra Albayat, Jawaher Alotaibi, Ali A. A. Al bshabshe, Ameen S. S. Alwashmi et al. · 2025 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  22. Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2
    Lena M. Rudy, Michał M. Godlewski · 2025 · International Journal of Molecular Sciences
  23. Classic psychedelics: past uses, present trends, future possibilities
    Adam Safron, Matthew W. Johnson · 2022
  24. Complementary and Alternative Therapies
    Joan E. Blakley · 2023 · Springer eBooks
  25. Behavioral effects of sub-anesthetic ketamine in a go/no-go task
    André Sevenius Nilsen, Bjørn Erik Juel, Nadine Farnes, Luis Georg Romundstad, Johan Frederik Storm · 2021 · Journal of Evolutionary Psychology
  26. An Overview of Alkaloids Derived from Tryptophan and Their Potential Antidepressant Action
    Maria Emanuelle Damazio Lima, Isian Santos da Silva, Mariana de Oliveira Leal Desmarais, Thais Cardoso de Oliveira, Davyson de Lima Moreira, Alessandra Leda Valverde · 2021 · Revista Virtual de Química
  27. What Conceptual Metaphors Appear in Texts on Psychedelics and Medicine? Corpus-Based Cognitive Study
    Milena Bryła · 2022 · Respectus Philologicus
  28. The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents
    Núria Nadal‐Gratacós, Pol Puigseslloses, Laura Guzmán, Nicola Weiss, Eline Pottie, Clara Riera-Colomer, Virginie Lardeux, Nathalie Thiriet, Fu-Hua Wang, Liselott Källsten et al. · 2025 · Molecular Psychiatry
  29. Knocking at the Doors of Perception: Relating LSD Effects on Low‐Frequency Fluctuations and Regional Homogeneity to Receptor Densities in fMRI
    Paolo La‐Torraca‐Vittori, Livio Tarchi, Elisa Arrigo, Stefano Lanterna, Eleonora Tosi, Arne Doose, Fulvia Palesi, Doris Pischedda, Valdo Ricca, Paolo Fusar‐Poli et al. · 2025 · European Journal of Neuroscience
  30. Thirty Years of Ibogaine Research
    Ewen Kervadec, Aurore Bezo, Raphaël Serreau, Lana Strika-Bruneau, Baptiste Fauvel, Ammar Amirouche, Amine Benyamina, Bruno Roméo · 2026 · Journal of Clinical Psychopharmacology
  31. Møter med det hellige: bruk av LSD,fleinsopp og andre psykedeliske stoffer
    Willy Pedersen · 2020 · Tidsskrift for samfunnsforskning
  32. Plantes psychotropes, médecines traditionnelles autochtones du Pérou et renaissance psychédélique
    IIana Berlowitz · 2022 · Drogues santé et société
  33. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung
    Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther · 2023 · Fortschritte der Neurologie · Psychiatrie
  34. Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists
    Payal Ghosh, Debjeet Sur · 2024 · Current Psychiatry Research and Reviews
  35. The romantic age of pharmacological science
    Jeffrey M. Witkin · 2022 · Pharmacology Biochemistry and Behavior
  36. Psychedelic revival: a mixed-methods analysis of recreational magic mushroom (psilocybin) use for transformational, micro-dosing and leisure purposes
    Lindsay Shaw · 2018 · UVic’s Research and Learning Repository (University of Victoria)
  37. Hallucinogens as Therapeutic Agents: Past, Present, and Future
    Elena Vos, Stephen Snelders, Toine Pieters · 2020 · Springer eBooks
  38. Faculty Opinions recommendation of Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.
    Eric Hollander, Genoveva Uzunova · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  39. Faculty Opinions recommendation of Psychedelics promote structural and functional neural plasticity.
    Edwin R. Chapman, Jason Vevea · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  40. Main Drugs of Abuse
    Ilari D’Aprile · 2021 · Elsevier eBooks
  41. Hallucinogens as Therapeutic Agents: Past, Present, and Future
    Elena Vos, Stephen Snelders, Toine Pieters · 2022 · Springer eBooks
  42. Estudios sobre la biosíntesis del metabolito secundario verbascósido en cultivos en suspensión de Buddleja cordata
    Hypatia Arano-Varela · 2021
  43. THE THERAPEUTIC POTENTIAL OF PSYCHEDELICS FOR MENTAL HEALTH DISORDERS: A REVIEW OF CURRENT EVIDENCE
    Chirag Ambaliya, Dimple Gupta, Ashok Vala, Krupa Mukeshbhai Unadkat · 2023 · PARIPEX-INDIAN JOURNAL OF RESEARCH
  44. Identificação morfológica de macrofungos das ordens Agaricales, Boletales e Polyporales (Agaricomycetes, Basidiomycota) na Floresta Nacional de Brasília(FLONA)
    André Víctor Frias Beserra, Stefano Salvo Aires · 2024 · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa
  45. AVANÇOS CLÍNICOS NO USO DE PSICODÉLICOS PARA TRANSTORNOS PSIQUIÁTRICOS: UMA REVISÃO INTEGRATIVA
    Alberto Almeida, Carlos Paulo da Silva, Clara Martin Guilherme Guerzoni, Ederaldo de Paula Oliveira, Edis Rodrigues Junior, Guilherme Ribeiro Jorge Mesquita, Higor Ruan Rosa, Izabela Christina Magalhães Malta Dionisio, Janaina Luiza Thomé, Karine Lis Rodrigues Luz et al. · 2024 · Revista fisio&terapia.
  46. A comparative study of effects of DOM and lisuride on neuronal activity in nucleus accumbens of freely moving rats
    Yan Wang, Kaili Jiang, Yishan Yao, Xiao‐Yan Liu, Ruibin Su · 2024 · European Journal of Pharmacology
  47. Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung
    Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther · 2025 · Nervenheilkunde
  48. Lysergic acid diethylamide inhibits status epilepticus and mortality in a mouse model of acute kainic acid-induced motor seizures
    Brenden Samuel Rabinovitch, W Hu, C Tang, N Silverman, Evan Cole Lewis, Peter Louis Carlen · 2025 · Next research.
  49. Neurogenic Potential of Acacia oerfota: Evaluating the Effects of DMT-Rich Extract on PC12 Cells
    Narges Ghasemi Lakeh, Mona Farhadi, Fatemeh Siadat · 2024 · Thrita journal of neuron.
  50. Behavioral and genetic analysis of the effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI) in C. elegans
    Amanda M. White, Adele D. Bauer, Serge Faumont, Shawn R. Lockery · 2025 · PLoS ONE
  51. INTERVENTIONS AND TREATMENT FOR THE EFFECTS OF ACEs
    Diane Riley, Richard Martin Pates · 2026
  52. The Neuropharmacology of Psychedelics
    Denis Pavăl · 2026 · SpringerBriefs in religious studies
  53. PAT-Sim: An Ethical Serious Game for Experiential Training in Psychedelic-Assisted Psychotherapy
    Tyler Reeds, Ishaan Kishore, Omid Fanaei, Rachel Marinic, Ivan Ho, Argyrios Perivolaris, Bill Kapralos, Allen Kalpin, David Chandross · 2026 · International Conference on Information, Intelligence, Systems & Applications (IISA)
  54. French psychiatric caregivers’ perceptions of psychedelics: A national survey
    Anne Buot, Jean-Del Burdairon, Luc Mallet, Raphaël Gaillard B, Benjamin Rolland, Lucie Berkovitch · 2026 · L Encéphale
  55. Quantum Chemical Topology and Energetic Analysis of Psychedelic and Non-Psychedelic Ligands in Coordination-Sphere Models of the Human 5-HT2A Receptor
    Anaid Flores, Imelda Lizeth Lazcano Carrasco, Mayra Lozano-Espinosa, Luis Antonio Soriano-Agueda, Carlos Zepactonal Gómez-Castro, Marco Franco‐Pérez · 2026 · Research Square